Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 128 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

17 trials in Phase 3/4

Results Transparency

2%

1 of 41 completed trials have results

Key Signals

26 recruiting1 with results

Enrollment Performance

Analytics

N/A
61(73.5%)
Phase 3
11(13.3%)
Phase 4
6(7.2%)
Phase 1
3(3.6%)
Early Phase 1
1(1.2%)
Phase 2
1(1.2%)
83Total
N/A(61)
Phase 3(11)
Phase 4(6)
Phase 1(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (128)

Showing 20 of 128 trials
NCT07441824Phase 3Recruiting

Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis

Role: lead

NCT06955520Not ApplicableRecruiting

Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM

Role: lead

NCT07399652Not ApplicableRecruiting

Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures

Role: lead

NCT07486518Not Yet Recruiting

A Multicentre Prospective Cohort Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

Role: lead

NCT07431983Recruiting

Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD

Role: lead

NCT06953986Not ApplicableRecruiting

A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks

Role: lead

NCT07413822Not ApplicableNot Yet Recruiting

A Single-centre Open, Prospective, Pilot Clinical Study to Assess the Safety and Performance of the TIES® Transcutaneous Implant System in Patients Requiring a Permanent Ileostomy or Colostomy

Role: lead

NCT07371832Recruiting

A Single Center Evaluation of AI Enabled SureForm Robotic Stapler (SureformTM) Compared to Conventional Stapler for Colorectal Cancer Procedures

Role: lead

NCT07411118Not ApplicableRecruiting

RCT of EFTR Versus STER for GIST Treatment

Role: collaborator

NCT07399054Not Yet Recruiting

Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU

Role: lead

NCT07307248Not ApplicableRecruiting

To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage

Role: lead

NCT07329803Not ApplicableNot Yet Recruiting

Pre-cut Versus Intentional Double Guidewire for ERCP Cannulation: Prospective, Randomized Controlled Trial

Role: lead

NCT07329816Not Yet Recruiting

External, Multicentre Validation of a Machine-Learning Model to Predict Colonic Adenoma in Indian Adults

Role: lead

NCT07329790Not Yet Recruiting

Indian National Study to Assess Incidence and Severity of Post-ERCP Pancreatitis After Following SOP

Role: lead

NCT07325071Not ApplicableNot Yet Recruiting

Comparison of Conventional and Short Submucosal Tunnel Techniques in Type II Achalasia

Role: lead

NCT07322978Recruiting

Incidence of Splanchnic Venous Thrombosis in Acute Pancreatitis and it's Correlation With Severity of Pancreatitis

Role: lead

NCT06066372Recruiting

Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis

Role: lead

NCT07283185Recruiting

Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis

Role: lead

NCT07293234Not ApplicableNot Yet Recruiting

Effect of Simethicone on Helicobacter Pylori Detection in Routine Endoscopy

Role: lead

NCT07297069Phase 2Not Yet Recruiting

Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial

Role: lead